Related Experiment Videos
BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned
Dickon Hayne1,2,3, Martin Stockler1,4, Steve P McCombie1,3
1Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia.
BJU International
|April 10, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Artificial Intelligence impact on decision-making regarding short-term ADT with prostate radiotherapy: ASTuTE clinical trial interim results.
Clinical and translational radiation oncology·2026
Diversity of Antarctic sea ice and under-ice seawater RNA viruses.
Applied and environmental microbiology·2026
Implementation science in hybrid randomized controlled trials: a state-of-the-art systematic review.
JBI evidence implementation·2026
Kidney stones composition prediction using artificial intelligence (KiSCAI) study.
BJU international·2026
The physiology of the upper urinary tract in endourological times - a narrative review.
BJU international·2026
Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.
Korean journal of radiology·2026
Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.
Transfusion medicine (Oxford, England)·2026